Brasilia (Brazil): The Brazilian Health Regulatory Agency (Anvisa) on Sunday approved the use of two vaccines against the coronavirus disease, developed by companies AstraZeneca and Sinovac.
The decision is said to have been made at the regulator’s meeting, paving the way for the nation to begin mass vaccination as the pandemic entered a deadly second stage.
Reuters reported, hours after the Anvisa unanimously voted for the two vaccines for emergency use authorization in the nation, a 54-years-old nurse in Sao Paulo, became the first person to be inoculated in the country who was jabbed with China-made Sinovac.
The vaccine approval comes after President Jaire Bolsonarro — a vaccine skeptic — has come under the pressure of the public to introduce vaccination against the novel coronavirus that so far killed over 200,000 in Brazil, a death toll second only to the US.
Reuters noted, delay in the approval process held up vaccine shipments in the nation, once a global-leader in mass inoculations. Now that the approval process is done, Brazil awaits shipment from AstraZeneca to kick off the vaccination drive at a much larger scale.
The experts noted the safety and effectiveness of those vaccines and requested the companies to continue providing information to Anvisa. As per reports, mass inoculations could wait until Wednesday to kick off.
India has a contract to ship some 2 million ready doses of Oxford’s vaccine to Brazil. Plans could be to innoculate upto 1 million people daily, Reuters reported.
Earlier, the regulator refused to grant Brazilian pharmaceutical company Uniao Quimica authorization for the emergency use of Russia’s Sputnik V vaccine.